We are live on
!
Find out more
BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.38B
AUM Growth
+$231M
(+3.2%)
Cap. Flow
+$238M
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
443
New
26
Increased
211
Reduced
155
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$135M |
| 2 |
PepsiCo
PEP
|
+$65.3M |
| 3 |
PNC Financial Services
PNC
|
+$61.9M |
| 4 |
Home Depot
HD
|
+$55.7M |
| 5 |
Hasbro
HAS
|
+$48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$80.6M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.1M |
| 3 |
US Bancorp
USB
|
+$65.3M |
| 4 |
McDonald's
MCD
|
+$50.1M |
| 5 |
Oneok
OKE
|
+$49.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.18% |
| 2 | Consumer Staples | 15.63% |
| 3 | Technology | 14.71% |
| 4 | Financials | 12.61% |
| 5 | Industrials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBRG
226
DELISTED
TruBridge
TBRG
| $911K | 0.01% |
16,773
+85
| +0.5% | +$4.66K |
|
227
Broadcom
AVGO
$2.02T
| $901K | 0.01% |
70,950
-29,480
| -29% | -$338K |
|
228
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $899K | 0.01% |
3,241
-44
| -1% | -$11.9K |
|
229
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
| $895K | 0.01% |
18,520
-45
| -0.2% | -$2.15K |
|
|
TUP
230
DELISTED
Tupperware Brands Corporation
TUP
| $892K | 0.01% |
12,930
-17,583
| -58% | -$1.19M |
|
231
HP
HPQ
$26.1B
| $878K | 0.01% |
62,022
+1,280
| +2% | +$21.1K |
|
232
Danaher
DHR
$141B
| $875K | 0.01% |
15,332
-49
| -0.3% | -$2.81K |
|
233
Texas Instruments
TXN
$258B
| $868K | 0.01% |
15,175
+1,700
| +13% | +$95.5K |
|
|
XEC
234
DELISTED
CIMAREX ENERGY CO
XEC
| $861K | 0.01% |
7,479
+1,744
| +30% | +$187K |
|
235
Rollins
ROL
$17.9B
| $855K | 0.01% |
77,758
+2,691
| +4% | +$27.1K |
|
236
Invesco Dividend Achievers ETF
PFM
$807M
| $849K | 0.01% |
39,845
+63
| +0.2% | +$1.36K |
|
237
SPDR Gold Trust
GLD
$141B
| $832K | 0.01% |
7,320
+1,535
| +27% | +$180K |
|
238
iShares Russell Mid-Cap ETF
IWR
$57.2B
| $825K | 0.01% |
19,056
+1,364
| +8% | +$58K |
|
239
United Natural Foods
UNFI
$2.83B
| $814K | 0.01% |
10,565
+370
| +4% | +$29K |
|
|
CMD
240
DELISTED
Cantel Medical Corporation
CMD
| $803K | 0.01% |
16,913
-3,530
| -17% | -$156K |
|
241
Mine Safety
MSA
$7.49B
| $798K | 0.01% |
15,994
+6,000
| +60% | +$290K |
|
242
Plains GP Holdings
PAGP
$4.92B
| $797K | 0.01% |
10,552
-113
| -1% | -$8.2K |
|
|
CB
243
DELISTED
CHUBB CORPORATION
CB
| $789K | 0.01% |
7,808
+390
| +5% | +$39.5K |
|
244
Brinker International
EAT
$9.77B
| $769K | 0.01% |
12,488
+455
| +4% | +$27.4K |
|
245
RB Global
RBA
$17.4B
| $762K | 0.01% |
30,539
+875
| +3% | +$22.3K |
|
246
J&J Snack Foods
JJSF
$1.68B
| $761K | 0.01% |
7,140
+255
| +4% | +$26.5K |
|
247
Eastman Chemical
EMN
$8.4B
| $760K | 0.01% |
10,980
+1,306
| +14% | +$94.3K |
|
248
Wabtec
WAB
$49.7B
| $752K | 0.01% |
7,915
+95
| +1% | +$8.57K |
|
249
S&T Bancorp
STBA
$1.81B
| $737K | 0.01% |
25,965
+14,735
| +131% | +$422K |
|
250
Monro
MNRO
$390M
| $733K | 0.01% |
11,265
+2,765
| +33% | +$169K |
|
Similar funds
NIM
HHII
SPIA
MIM
EIM
OSAM
P
Bahl & Gaynor's Q1 2015 Portfolio in Review
As of Q1 2015, Bahl & Gaynor held 443 positions worth $7.38B, up 3.2% from $7.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Bahl & Gaynor deployed $238M of net new capital in Q1 2015, opening 26 new positions and adding to 211 existing holdings. Its largest new stake was Blackstone: 24,777 shares worth $946K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Baxter International, an estimated $80.6M trimmed.
- Bahl & Gaynor's largest Q1 2015 buy was Blackstone: 24,777 shares worth $946K.
- Bahl & Gaynor added most to Pfizer in Q1 2015, an estimated $135M increase.
- Bahl & Gaynor's biggest Q1 2015 reduction was Baxter International, cutting an estimated $80.6M.
- Bahl & Gaynor fully exited MWI VETERINARY SUPPLY, INC. in Q1 2015, selling an estimated $650K.
- Bahl & Gaynor's ten largest holdings make up 24% of its $7.38B portfolio in Q1 2015.
- Bahl & Gaynor opened 26 new positions and closed 11 in Q1 2015.
- Bahl & Gaynor's portfolio value rose 3.2% quarter-over-quarter to $7.38B.
Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.